Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Pulse Biosciences, Inc. PLSE
$8.26
+$0.71 (8.54%)
На 18:01, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
312288810.00000000
-
week52high
9.69
-
week52low
1.18
-
Revenue
700000
-
P/E TTM
-4
-
Beta
1.11003400
-
EPS
-2.27000000
-
Last Dividend
0.00000000
-
Next Earnings Date
11 мая 2023 г. в 20:00
Описание компании
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
Рекомендации
аналитиков
Рекомендации аналитиков
Grading company | New grade | Previous grade | Recommendation date |
---|---|---|---|
HC Wainwright & Co. | Neutral | Buy | 13 мая 2022 г. |
Stephens & Co. | Overweight | Overweight | 01 апр 2022 г. |
HC Wainwright & Co. | Buy | Buy | 01 апр 2022 г. |
HC Wainwright & Co. | Buy | Buy | 10 февр 2022 г. |
HC Wainwright & Co. | Buy | Buy | 16 ноя 2021 г. |
Maxim Group | Hold | Buy | 21 сент 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
---|---|---|---|---|
Levinson Mitchell E. | A | 5034 | 4300 | 07 окт 2022 г. |
Levinson Mitchell E. | A | 5234 | 4500 | 07 окт 2022 г. |
Levinson Mitchell E. | A | 5134 | 4400 | 07 окт 2022 г. |
Levinson Mitchell E. | A | 12945 | 8810 | 07 окт 2022 г. |
Levinson Mitchell E. | A | 46274 | 8770 | 07 окт 2022 г. |
Danahy Kevin Patrick | A | 6500 | 6500 | 30 сент 2022 г. |
Danahy Kevin Patrick | A | 450000 | 450000 | 23 сент 2022 г. |
DUGGAN ROBERT W | A | 81025 | 81025 | 09 июн 2022 г. |
DUGGAN ROBERT W | A | 5683163 | 5683163 | 09 июн 2022 г. |
DUGGAN ROBERT W | A | 411044 | 81025 | 09 июн 2022 г. |
Новостная лента
Pulse Biosciences, Inc. (PLSE) Q1 2023 Earnings Call Transcript
Seeking Alpha
11 мая 2023 г. в 21:59
Pulse Biosciences, Inc. (NASDAQ:PLSE ) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ET Company Participants Trip Taylor - Investor Relations Kevin Danahy - President & Chief Executive Officer Darrin Uecker - Chief Technology Officer Mike Koffler - Vice President of Finance Robert Duggan – Executive Chairman Conference Call Participants Robert Lovgren – Medical Hope Productions Operator Good afternoon, ladies and gentlemen and thank you for standing by. Welcome to the Pulse Biosciences First Quarter 2023 Earnings Conference Call.
Pulse Biosciences Inc. (PLSE) Q4 2022 Earnings Call Transcript
Seeking Alpha
30 мар 2023 г. в 20:41
Pulse Biosciences Inc. (NASDAQ:PLSE ) Q4 2022 Earnings Conference Call March 30, 2023 4:30 PM ET Company Participants Trip Taylor – Investor Relations Kevin Danahy – President and Chief Executive Officer Darrin Uecker – Chief Technology Officer Robert Duggan – Executive Chairman Conference Call Participants Robert Lovgren – Medical Hope Productions James Hollingsworth – Private Investor Operator Ladies and gentlemen, greetings, and welcome to the Pulse Biosciences' Fourth Quarter 2022 Earnings Conference Call. At this time all participants lines are in a listen-only mode.
Pulse Biosciences, Inc. (PLSE) Q3 2022 Earnings Call Transcript
Seeking Alpha
10 ноя 2022 г. в 20:02
Pulse Biosciences, Inc. (NASDAQ:PLSE ) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Philip Taylor – Investor Relations, Gilmartin Group Kevin Danahy – President and Chief Executive Officer Darrin Uecker – Chief Technology Officer Sandy Gardiner – Executive Vice President and Chief Financial Officer Conference Call Participants Operator Greetings and welcome to Pulse Biosciences Third Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Hot Penny Stocks To Watch As The Stock Market Crash Continues
PennyStocks
26 сент 2022 г. в 14:30
Hot penny stocks to add to your watch list this week. Is it time to buy?
Pulse Biosciences, Inc. (PLSE) CEO Darrin Uecker on Q2 2022 Results - Earnings Call Transcript
Seeking Alpha
10 авг 2022 г. в 19:40
Pulse Biosciences, Inc. (NASDAQ:PLSE ) Q2 2022 Earnings Conference Call August 10, 2022 4:30 PM ET Company Participants Philip Taylor - Investor Relations, Gilmartin Group Darrin Uecker - President and Chief Executive Officer Kevin Danahy - Chief Commercial Officer Sandra Gardiner - Executive Vice President and Chief Financial Officer Conference Call Participants Jeremy Pearlman - Maxim Group LLC Swayampakula Ramakanth - H.C. Wainwright & Co, LLC Operator Greetings, and welcome to Pulse Biosciences Second Quarter 2022 Earnings Conference Call.